Waycross Partners’s Organon & Co OGN Stock Holding History

Waycross Partners’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-550	Closed	-$3.29K	–	78
2026 Q1	$3.29K	Buy	+550	New	+$4.14K	﹤0.01%	76

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Waycross Partners's OGN Position: Q2 2026 in Review

Waycross Partners sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 550 shares — an estimated $3.29K sold.

Waycross Partners first reported a position in OGN in Q1 2026 and held it in 1 quarter. The position peaked at $3.29K in Q1 2026. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Waycross Partners reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
Waycross Partners sold 550 Organon & Co shares in Q2 2026, an estimated $3.29K.
Waycross Partners first reported a position in Organon & Co in Q1 2026 and held it in 1 quarter.
Waycross Partners's Organon & Co position peaked at $3.29K in Q1 2026.
633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Waycross Partners's 13F filing for Q2 2026, filed 11 Aug 2026.